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A B S T R A C T   
Per- and polyfluoroalkyl substances (PFAS) have been extensively used as surfactants because of their high 
stability and good water/oil-repellent properties. PFASs, especially perfluoroalkyl acids (PFAAs), have long 
biological half-lives, and exposure may cause adverse health effects in humans. We assessed temporal trends of 
concentrations of eight PFAAs in serum of Swedish adolescents (age 16–21 years) from the general population, 
and estimated the stability of PFAAs and serum samples after 6 years of storage. Repeated cross-sectional 
sampling was performed on five occasions (covering in total 1213 individuals, 83% males) in southern Swe-
den between 2000 and 2017. We analyzed serum for perfluorohexane sulfonic acid (PFHxS), perfluorooctane 
sulfonic acid (PFOS), perfluoroheptanoic acid (PFHpA), perfluorooctanoic acid (PFOA), perfluorononanoic acid 
(PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUnDA), and perfluorododecanoic acid 
(PFDoDA) using liquid chromatography-tandem mass spectrometry. We assessed time trends using linear 
regression, long-term stability was assessed by reanalyzing samples collected 2013, and the comparison was done 
using Pearson correlation and Bland-Altman plots. 
PFHxS, PFOS, and PFOA decreased by 6.7% (CI: –7.0, –6.3%), 12.6% (CI: –12.9, –12.3%), and 6.5% (CI: –6.8, 
–6.1%) per year, respectively, and year of sampling explained 48–81% of the variation in concentrations. PFNA 
and PFDA seemed to increase up to 2009 and decrease thereafter. The trends were consistent after sensitivity 
analyses excluding women. Strong correlations of 94–97% were observed for concentrations of all compounds, 
except PFHxS, after storage. The observed trends closely followed the timing of manufacturers’ voluntary phase- 
out initiatives, and of regulatory measures governing the compounds implemented in the EU and USA. This 
indicates that these actions mitigated the population’s exposure to PFHxS, PFOS, and PFOA and, in recent years, 
to PFNA and PFDA, in southern Sweden. Furthermore, the results suggest that PFAAs remain stable in serum 
samples after long-term storage.   
1. Introduction 
Per- and polyfluoroalkyl substances (PFASs) are persistent synthetic 
chemicals for which there is evidence that exposure can cause adverse 
health effects in humans. The strong carbon–fluorine bond makes PFASs, 
perfluoroalkyl acids (PFAAs) in particular, very stable and resistant to 
chemical and biological degradation (Buck et al., 2011; Kissa, 2001). 
These compounds have been extensively used since the 1950s in various 
applications to create products that repel water, oil, and dirt and resist 
high temperatures (Buck et al., 2011; Kissa, 2001). PFASs are mainly 
used as surfactants in commercial and industrial products such as 
textiles, paper, food packaging, cookware, outdoor gear, furniture, and 
firefighting foams (Sunderland et al., 2018). 
The general population is mainly exposed to PFAS through food, 
drinking water, consumer products, indoor air, and dust (D’Hollander 
et al., 2010; Haug et al., 2011; Schrenk et al., 2020). Very high exposure 
may also occur through drinking water in areas where water reservoirs 
close to airports and military bases have been contaminated by fire-
fighting foam (Domingo and Nadal, 2019; Gyllenhammar et al., 2015; 
Kärrman et al., 2011; Li et al., 2018). PFASs are water soluble and, 
unlike other persistent organic pollutants, do not bind to organic matter 
to a large degree and can easily migrate from point sources to eventually 
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reach ground- and surface water (Banzhaf et al., 2017). 
The high persistence of PFAAs was not discovered until the early 
2000s when measurable concentrations of perfluorooctane sulfonic acid 
(PFOS) were found in wildlife and biota in the Arctic region (McInnis 
et al., 2017; Routti et al., 2019). In the year 2000, the worldwide 
manufacturer 3M initiated a phase-out of PFOS and related compounds 
from their products in agreement with the US EPA (Butenhoff et al., 
2006). In 2009, PFOS was also banned in the European Union (European 
Parliament Directive, 2006) and included in the Stockholm Convention 
on Persistent Organic Pollutants (SCPOP, 2009). Furthermore, the pro-
duction and use of perfluorooctanoic acid (PFOA) were phased out by 
major manufacturers in the USA by 2015. PFOA and its homologs and 
precursors were included in the Stockholm Convention in 2019 and will 
be phased out in the EU starting in 2020 (European Parliament Direc-
tive, 2017). Despite these measures, concentrations of both PFOS and 
PFOA are still detected in the environment, biota, and humans because 
of their persistence and long biological half-lives. 
PFAAs mainly bind to serum proteins such as albumin and accu-
mulate in the blood (Chi et al., 2018; Jin et al., 2019). Studies have 
suggested elimination half-lives in human serum or plasma of around 
2–4 years for PFOA, 3–5 years for PFOS, and 5–8 years for per-
fluorohexane sulfonic acid (PFHxS) (Li et al., 2018; Olsen et al., 2017). 
Sex-related differences have been observed in the elimination rates, 
partly explained by increased excretion among women through men-
strual bleeding or transfer during pregnancy and breast-feeding (Gor-
alczyk et al., 2015; Harada et al., 2005; Li et al., 2018). 
Epidemiological studies have shown associations between levels of 
PFAAs and health effects in humans. Based on currently available data, 
the European Food Safety Authority (EFSA) has concluded that 
decreased antibody response at vaccination in toddlers is the most 
critical effect (Schrenk et al., 2020). Some previous human bio-
monitoring studies of PFAAs in populations have assessed changes over 
time, with results indicating a decrease in concentrations of PFOS and 
PFOA over the last two decades in various countries (Olsen et al., 2017; 
Toms et al., 2014). For other PFASs, the reported trend patterns diverge 
between studies, probably due to differences in the study design, study 
period, and population composition (Göckener et al., 2020; Kim et al., 
2020; Miaz et al., 2020; Wang et al., 2020). Previous studies have not 
systematically assessed time trends over an extensive period. Studies of 
well-defined populations with sufficient statistical power are therefore 
needed to follow up the effects of the actions taken to eliminate envi-
ronmental pollution from PFASs during the specific period marked by 
major changes in production and use of these compounds. 
Biomonitoring PFAA concentrations in serum provides a reliable 
measure of the total cumulative exposure from all sources and can be 
used as a tool for following up the efficacy of legislative efforts to reduce 
human exposure. Biomonitoring studies often rely on material from 
biobanks or samples that were collected long ago and that have been 
stored for several years. Storing serum samples for long periods might 
impair sample quality and, to some extent, the stability of compounds. 
Estimates of sample quality, evaporation, and the long-term stability of 
PFASs in stored samples through reanalysis after storage are therefore of 
great importance for the reliability and interpretation of such data, 
although few studies address the issue (Kato et al., 2013). 
The main objective of this study was to assess exposure concentra-
tions and temporal trends from 2000 to 2017 of perfluorohexane sul-
fonic acid (PFHxS), perfluorooctane sulfonic acid (PFOS), 
perfluoroheptanoic acid (PFHpA), perfluorooctanoic acid (PFOA), per-
fluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), per-
fluoroundecanoic acid (PFUnDA), and perfluorododecanoic acid 
(PFDoDA) in serum from Swedish adolescents from the general popu-
lation to estimate the efficacy of the implemented regulatory measures. 
Furthermore, we addressed the sample integrity and compound stability 
in serum samples after up to six years of storage. 
2. Methods and materials 
2.1. Sample collection 
We used a repeated cross-sectional study design in which samples 
were collected on five occasions in 2000, 2004, 2009, 2013, and 2017. 
Initially, male study participants were recruited through the enrolment 
for military service in Scania (the southernmost county in Sweden) in 
2000 (n = 303), 2004 (n = 200), and 2009 (n = 314) through the Na-
tional Service Administration in Sweden. Following the decision for the 
peacetime deactivation of military conscription in Sweden between 
2010 and 2017, study participants were then recruited from secondary 
schools in Scania in 2013 and 2017 and included both males and females 
(n = 185 and n = 211, respectively). We initially contacted several 
schools in Scania County about participating in the study, three of 
which, in Lund (a municipality with 120,000 inhabitants in 2017) and 
Trelleborg (a municipality with 45,000 inhabitants in 2017), accepted. 
We performed recruitment and sample collection in the school facilities 
during the same week. All study participants were 16–21 years old. Two 
research nurses collected the venous blood samples from the partici-
pants. Serum was separated on the same day and transferred from glass 
sample vials to 2-mL plastic vials, which were stored at –80 ◦C until 
analyses. Population characteristics have previously been described 
elsewhere (Norén et al., 2020). 
2.2. Chemical analysis 
The analyses of serum samples were performed at the Division of 
Occupational and Environmental Medicine at Lund University. A 
modified method previously described by Lindh et al. (2012) was 
applied. Briefly, serum proteins were precipitated with acetonitrile and 
centrifuged directly in 96-well plates before analysis. The compounds 
PFHxS, PFOS, PFHpA, PFOA, PFNA, PFDA, PFUnDA, and PFDoDA were 
analyzed in the samples using liquid chromatography-tandem mass 
spectrometry (LC-MS/MS; QTRAP 5500, AB Sciex, Framingham, MA, 
USA). Two quality-control (QC) samples, four chemical blanks, and 
calibration standards were included in each sample batch. Concentra-
tions were determined as the total non-isomer-specific compounds. All 
values were corrected for the chemical blank. The limit of quantification 
(LOQ) was defined as the mean concentration in the chemical blanks 
plus ten times the standard deviation of the concentrations corre-
sponding to the peak with the same retention time as the PFAAs in the 
chemical blanks included in each 96-well plate. The LOQ was deter-
mined as 0.1 µg/L for all compounds. All samples were analyzed be-
tween 2018 and 2020. For PFHxS, the transitions m/z 399/80 and 399/ 
99 were evaluated, and we consequently used the lower value of the two 
since possible interferences have been suggested (Chan et al., 2009). 
Furthermore, the serum samples collected in 2013 were analyzed both in 
2014 and 2020 using the same instruments and method with minor 
improvements, performed by a different lab technician. However, when 
analyzing PFHxS in 2014, only m/z 399/80 was evaluated and in the 
comparison of PFHxS concentrations in 2013 samples between analyses 
in year 2014 and 2020, we therefore only used the 399/80 transition 
from both analyses. By comparing the concentrations of seven PFAAs in 
the 2013 samples from the analysis in 2014 and 2020, the long-term 
stability and sample integrity could be assessed. Details and modifica-
tions are presented in Supplementary Material A. The laboratory par-
ticipates in the ICI/EQUAS exercises for analyses of PFHxS, PFOS, 
PFHpA, PFOA, PFNA, PFDA, PFUnDA, and PFDoDA and is approved by 
the HBM4EU project (Supplementary Material B1). In addition, the 
analyses of PFOS and PFOA were certified by a quality control program 
between analytical laboratories, coordinated by Professor Hans Drexler 
at the Institute and Outpatient Clinical for Occupational, Social and 
Environmental Medicine, University of Erlangen-Nuremberg (Supple-
mentary Material B2, B3). 
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2.3. Statistical analysis 
Serum concentrations followed a log-normal distribution and were 
summarized using non-parametric descriptive statistics for each sam-
pling year and stratified by sex for 2013 and 2017. We assessed pairwise 
correlations for PFAA concentrations using Spearman’s rank-order cor-
relations for 2000 and 2017. Visual assessment of the linearity of time 
trends was performed using boxplots (log-scale), including the measured 
concentrations below LOQ. When the boxplots suggested that linearity 
was plausible, we used linear regression to assess the annual change in 
serum concentrations by regressing ln-transformed concentrations on 
calendar year. β coefficients were transformed to percent according to 
(exp(β) − 1 )*100) = %change. We performed residual analyses through 
visually assessing QQ plots. Concentration outliers were identified as 
data points with standardized residuals of >3 or <–3. These were 
considered influential observations and excluded from the model. When 
the assumption of linearity was violated, we explored quadratic terms 
that were centered around the mean to avoid collinearity. Some of the 
observations below LOQ, mainly for PFDA, were still included in the 
statistical models even though these values have a high level of uncer-
tainty. Applying a method of fixed substitution may dilute the variability 
of the material, which could affect observations of trends. We did not 
evaluate trends for compounds for which >30% of the observations 
were below LOQ. We conducted a sensitivity analysis from which 
women were excluded. We assessed the stability of the PFAAs in serum 
and the sample quality after storage for samples collected in 2013 by 
means of Pearson correlation, comparing the results of the initial anal-
ysis in 2014 and those of the reanalysis in 2020 using the same method 
with minor improvements (Supplementary Material A1). Additionally, 
we explored the agreement through Bland Altman plots, a methodo-
logical approach to quantify the agreement between two analytical 
measurements (Altman and Bland, 1983). We used the analysis in 2014 
as the reference method on the x-axis and plotted it against the relative 
difference. We plotted (analysis 2020–analysis 2014/analysis2014 * 100) 
on the y-axis (Giavarina, 2015). Limits of agreement were defined as 
mean difference ± 1.96 STD of percentual difference. The statistical 
analyses were performed using IBM SPSS Version 24.0 (IBM SPSS Sta-
tistics for Windows, Armonk, NY, USA). Pearson correlation plots of 
stability and the conversion of estimates to percentages were performed 
using Microsoft Excel 2011. 
3. Results 
PFHxS, PFOS, PFOA, PFNA, and PFDA were present in quantifiable 
concentrations in more than 85% of the samples (Table 1). The boxplots 
suggested log-linear associations for PFHxS, PFOS, and PFOA (Fig. 1). 
This was confirmed by the linear regressions, which showed that these 
three compounds decreased over the sampling period, PFOS by 12.6%, 
PFOA by 6.5%, and PFHxS by 6.7% per year (Table 2). The variation in 
concentration explained by sampling year was 81% for PFOS, 58% for 
PFOA, and 44% for PFHxS. We only observed minor differences of up to 
0.5 µg/L in median concentrations of PFOS and PFHxS between males 
and females (Supplementary Material A2). The linear trends for PFHxS, 
PFOS, and PFOA were robust and remained after excluding females, 
with only minor differences in estimates (Supplementary Material A2). 
No linear trends were observed for PFNA and PFDA, for which the 
regression of quadratic terms indicated an inversed u-shaped pattern in 
serum concentrations over time, with an increase from 2000 to 2009 
Table 1 
Descriptive statistics for serum concentrations (µg/L) and quantification frequency (%) of perfluoroalkyl acids in adolescents in southern Sweden.  
Compound Year n % > LOQ Median (IQR) 95th percentile Maximum 
PFHxS 2000 301 100 1.0 (0.8–1.3) 2.1 37.1  
2004 200 100 0.9 (0.7–1.0) 2.0 8.3  
2009 288 100 0.6 (0.5–0.7) 1.4 10.2  
2013 201 100 0.5 (0.4–0.6) 1.1 11.1  
2017 193 97 0.4 (0.3–0.5) 0.8 1.9  
PFOS 2000 300 99 21.4 (17.2–26.5) 38.9 76.9  
2004 200 100 17.2 (14.0–22.3) 34.3 56.9  
2009 288 100 7.0 (5.6–9.0) 13.2 21.5  
2013 201 100 3.4 (2.6–4.5) 6.5 9.1  
2017 195 100 2.6 (1.88–3.6) 6.2 10.2  
PFHpA 2000 300 25 0.1 (<LOQ–0.1) 0.2 0.7  
2004 200 37 0.1 (<LOQ–0.1) 0.4 7.4  
2009 288 12 <LOQ (<LOQ–0.1) 0.2 0.5  
2013 201 8 <LOQ (<LOQ–0.1) 0.1 0.5  
2017 195 4 <LOQ (<LOQ–<LOQ) 0.1 0.3  
PFOA 2000 300 99 3.6 (2.9–4.4) 6.0 9.7  
2004 200 100 3.0 (2.5–3.8) 5.4 13.3  
2009 288 100 2.5 (2.1–3.0) 4.1 6.1  
2013 201 100 1.7 (1.3–2.1) 3.2 7.9  
2017 195 100 1.1 (0.9–1.4) 1.9 3.1  
PFNA 2000 300 99 0.4 (0.3–0.5) 0.7 1.0  
2004 200 100 0.5 (0.4–0.6) 0.9 4.6  
2009 288 100 0.5 (0.4–0.6) 1.0 1.9  
2013 201 100 0.4 (0.4–0.6) 1.0 2.6  
2017 195 100 0.4 (0.3–0.5) 0.7 1.6  
PFDA 2000 300 85 0.1 (0.1–0.2) 0.3 0.4  
2004 200 98 0.2 (0.2–0.3) 0.4 1.0  
2009 288 100 0.3 (0.2–0.3) 0.4 0.9  
2013 201 95 0.2 (0.1–0.3) 0.5 1.0  
2017 195 93 0.2 (0.1–0.2) 0.4 0.9  
PFUnDA 2000 300 51 0.1 (<LOQ–0.1) 0.2 0.5  
2004 200 70 0.1 (<LOQ–0.2) 0.3 0.4  
2009 288 72 0.2 (<LOQ–0.2) 0.3 0.6  
2013 201 66 0.1 (<LOQ–0.2) 0.3 0.7  
2017 195 65 0.1 (<LOQ–0.2) 0.3 0.7  
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followed by a decline up to 2017 (Fig. 2). Strong correlations were 
observed between PFAA in the serum samples, but the pattern of 
bivariate correlations changed over time (Supplementary Material A2). 
Trends were not further assessed for PFHpA, PFUnDA, and PFDoDA, as 
more than 30% of the samples had concentrations below LOQ in mul-
tiple sampling years. 
In the comparisons between the analyses performed in 2014 and 
2020 of samples collected in 2013, the concentrations of PFOS, PFHpA, 
PFOA, PFNA, PFDA, and PFUnDA correlated very well between 
analytical batches, with r coefficients between 0.94 and 0.99. The cor-
relation of PFHxS concentrations was 0.87. Coefficients of determina-
tion were above 94% for all compounds except PFOS (88%) and PFHxS 
(75%) (Supplementary Material A2). Bland Altman plots showed a 
minor bias between the analyses 2014 and 2020 varying between − 11% 
and 3% for all compounds, except PFHxS with a mean difference of 
− 18% (Fig. 3). The percentual limits of agreement were generally nar-
row, except for PFHxS and PFDUnDA. We did not observe any trend in 
the bias for any compound but a tendency to consistently higher con-
centrations of PFHxS in the initial analysis 2014. 
4. Discussion 
Concentrations of PFAAs in serum are in part a measurement of cu-
mulative exposure up to the time of sampling because of very long 
elimination half-lives. The high detection frequencies of PFHxS, PFOS, 
PFOA, PFNA, and PFDA indicate widespread PFAA exposure among 
Year







































































































Fig. 1. Serum concentrations of PFAA, concentrations in serum (log-scale) of metabolites: a PFHxS, b PFOS, c PFHpA, d PFOA, e PFNA, f PFDA, and g PFUnDA in 
adolescents in southern Sweden plotted against sampling year. 
Table 2 
Assessment of temporal trends through linear regression: PFAA (ln-transformed) 
on calendar year excluding outliers (standardized residual <–3, >3). Regression 
coefficient (β) and 95% confidence intervals are converted to %.  
Compound n total (n excluded) β (%) 95 CI (%) p R2 
PFHxS 1165 (19) –6.7 –7.0, –6.3 <0.001 0.48 
PFOS 1174 (10) –12.6 –12.9, –12.3 <0.001 0.81 
PFOA 1173 (11) –6.5 –6.8, –6.1 <0.001 0.58  
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adolescents in southern Sweden. However, the decreasing trends 
observed for PFHxS, PFOS, and PFOA demonstrate that important 
exposure sources of these compounds have been eliminated. Although a 
delay in the initiation of decreasing trends was observed for PFNA and 
PFDA, the observed decreasing trends between 2000 and 2017 may, as 
for PFHxS, PFOS, and PFOA, be related to the voluntary phase-out by 
industry and to the international regulatory actions taken against PFAS 
pollution during the same period. The reanalysis of PFAAs in serum 
samples after six years of storage showed that the sample integrity re-
mains unimpaired and the compounds remain stable, thus being reliable 
for human biomonitoring of trends in exposure. 
4.1. Time Trends, 2000–2017 
PFOS was consistently detected at the highest serum concentrations 
on all sampling occasions, despite being phased out of production by its 
main manufacturer (3M) in 2002 and restrictions for use being enforced 
in the EU starting in 2009. The decreasing trends of PFOS show that the 
phase-out starting in 2002 resulted in decreased body burdens of PFOS 
in Sweden within a few years. Consequently, our results strongly suggest 
that important human exposure pathways of PFOS were cut around 
2002, although some production continued or began in China after the 
3M phase-out (Jiang et al., 2015; Jin et al., 2015). One such important 
exposure pathway was the use of PFOS and related compounds in food- 
contact materials. Before the year 2000, about 30% of the PFOS used in 
the EU was utilized for paper coating (UNEP-POPRC, 2010). Further 
risk-reducing measures after 2002, such as the inclusion of PFOS in the 
EU POPs Directive and the Stockholm Convention, ensured that actions 
were taken against important remaining exposure pathways. A similar 
pattern and decreasing trend could be observed for PFHxS, likely 
explained by actions to phase out PFHxS and related compounds taken 
by the main producer, similar to those taken for PFOS (UNEP-POPRC, 
2018). The longer elimination half-life in humans may explain the 
slower rate of PFHxS decline as compared with PFOS during the studied 
period (Li et al., 2018). 
Serum concentrations of PFOA decreased at a slower rate than did 
those of PFOS, even though PFOA and related compounds were phased 
out of production by 3M at the same time as was PFOS. However, many 
other manufacturers of PFOA remained, which could explain why the 
3M phase-out did not have the same immediate impact on serum con-
centrations of PFOA over time as it did for PFOS and PFHxS. Never-
theless, several of these additional manufacturers later agreed to phase 
out PFOA and related compounds in agreement with the US EPA through 
the voluntary PFOA Stewardship Program, which started in 2008 and 
finished in 2015 (US EPA, 2006). Overall, the year explained a large 
proportion of the variation in concentrations over time of PFOS, PFHxS, 
and PFOA in our models, further indicating that the phase-out of pro-
duction had a significant impact on exposure. 
For PFHpA, PFNA, PFDA, and PFUnDA, concentrations were low and 
temporal trends were less clear. PFNA and PFDA concentrations 
increased between 2000 and 2009 followed by a decline between 2009 
and 2017. Both PFNA and PFDA are long-chain perfluoro-carboxylic 
acids (PFCAs), together with PFOA included in the PFCA group with 
eight or more carbons in the molecule (“C8”). The observed decline in 
serum concentrations after 2009 coincides with the voluntary agree-
ment between the US EPA and several large manufacturers to phase out 
C8 compounds as grease-proofing agents in paper food contact materials 
by 2011, along with the revoked approval for the use of these C8 com-
pounds in food contact materials in 2015 (US FDA, 2016, 2019). 
Other studies frequently report PFOS as the dominant PFAA detected 
in serum collected during the same period in US adolescents (Calafat 
et al., 2007), Faroese adolescents (Grandjean et al., 2017), and US 
children in 2011 (Gump et al., 2011). Decreasing concentration trends of 
the phased-out compounds PFOA, PFOS, and PFHxS have been observed 
in other studies after the year 2000 (Bjerregaard-Olesen et al., 2016; 
Calafat et al., 2007; Jain, 2018; Nøst et al., 2014; Olsen et al., 2017; Tsai 
et al., 2018). Diet is considered the main source of exposure in the 
general population (Domingo and Nadal, 2017), and measurements of 
decreasing concentrations of PFHxS and PFOS in food items, mainly 
animal products, in Sweden between 1999 and 2011 are therefore also 
in line with our findings (Johansson et al., 2014). For PFNA and PFDA, 
temporal trends of serum concentrations are less consistent over time, 
with observations of both increasing and decreasing trends, but 
decreasing trends seem to be consistently reported in studies published 
after 2010 (Bjerregaard-Olesen et al., 2016; Okada et al., 2013; Olsen 
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Fig. 2. Assessment of nonlinear trends by regressing quadratic terms of ln-transformed concentrations of a PFNA (R2 = 0.16) and b PFDA (R2 = 0.21) on calen-
dar year. 
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Fig. 3. Agreement of analyses in serum samples before and after 6 years of storage for a PFHxS, b PFOS, c PFOA, d PFNA, e PFDA, f PFUnDA through Bland Altman- 
plots. Relative difference (%) between measurements on the y-axis and measured concentrations (µg/L) of the reference method in 2014 on the x-axis. 
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starting around 2010 fit well with the agreement to phase out these 
compounds between the main manufacturers and the US EPA by 2011 
(US FDA, 2016, 2019). 
In the year 2000, a strong correlation was observed between PFOS 
and PFOA concentrations in serum, whereas in 2017, the PFOS con-
centration was instead strongly correlated with PFDA, PFNA, and 
PFUnDA concentrations. Correlations indicate common exposure sour-
ces and the change in correlation patterns over time suggests that there 
may have been a shift in exposure sources over time. It could be spec-
ulated that food contact materials were common sources of PFOA and 
PFOS exposure early in the study period, and with the phase-out of these 
uses, other sources of exposure began to dominate. This is supported by 
a market basket study by the National Food Agency in Sweden that 
estimated the per capita intake of PFAAs from different food groups in 
2015. For PFOA, cereals dominated the intake, while fish and meat 
dominated the intake of other long-chained PFCAs and PFOS (National 
Food Agency, 2017). PFHpA has not been found to a large extent in food 
items analyzed in Sweden, which could explain the very low or unde-
tectable concentrations in adolescent serum. These results further 
confirm that the general population is continuously exposed to a mixture 
of these compounds and that the composition of this mixture changes 
over time, which needs to be taken into consideration in risk 
assessments. 
To explore whether some exposure to PFOS and PFOA was still 
ongoing after the phase-out, or whether decreasing temporal trends 
were due to a complete cessation of exposure, we made a crude com-
parison of the estimated rates of temporal decline, expressed as temporal 
trend half-life, and the estimated biological half-lives of PFOS and PFOA 
in serum at 3.4 years and 2.7 years, respectively, published by Li et al. 
(2018). The figures and calculations with our transformed data are 
available in Supplementary Material A2. Based on our median concen-
trations, the half-lives of the trends in adolescents were estimated to be 
5.0 years for PFOS and 9.9 years for PFOA, which is longer than the 
biological half-lives, suggesting that some exposure to these compounds 
was still occurring through 2017. The longer temporal trend half-life of 
PFOA than of PFOS may be due to the slower phase-out of PFOA pro-
duction than of PFOS production by the main manufacturers outside 
China. 
4.2. Compound stability and sample integrity after storage 
The comparisons of PFAA concentrations in the re-analyses per-
formed in 2014 and 2020 of the same samples collected in 2013 showed 
that concentrations of five of the analyzed PFAAs remained stable in 
serum samples after storage at –80 ◦C for up to 6 years, and that the 
samples did not appear to have evaporated. This was expected based on 
the stability of the compounds, but this finding also confirms that the 
analytical method was robust and well validated, yielding very similar 
results despite being performed by different technicians and on different 
occasions. The exception was PFHxS and to some extent PFOS, for which 
there was a lower correlation between the results. We did not observe 
any trends of relative bias depending on concentrations of PFOS, PFOA, 
PFNA, PFDA, and PFDUnDA in 2014 in the Bland-Altman plots. The 
variation between the compounds indicate that it is not likely that the 
bias is related to the sample integrity. Both PFHxS and PFDUnDA had 
wider limits of agreement than other compounds. For PFUnDA, this is 
probably explained by the low concentrations observed, where analyt-
ical precision always is a challenge. A similar pattern could be observed 
for several compounds, that the difference is greater for data points in 
the lowest concentration range. For PFHxS, it has been suggested that 
interferences from co-eluting compounds could result in overestimation 
of the results when only the m/z 399/80 transition is used. Chan et al. 
(2009) proposed that metabolites from progesterone could interfere in 
the analysis of PFHxS. Therefore, this comparison of m/z 399/80 of 
PFHxS should be taken with caution. Furthermore, we analyzed the total 
non-isomer specific PFOS in this study and there were some indications 
of interferences for this compound as well, possibly connected to bile 
acids (Benskin et al., 2007), which could explain the slightly wider limit 
of agreement observed. Still, no specific pattern was observed for all 
compounds which indicated that the observed differences did not 
depend on impaired sample integrity. The observed bias between the 
analyses are here considered acceptable and in the same range as the 
coefficients of variation observed in the between-run precision (Sup-
plementary material), considering that the whole method, including 
sample preparation, analysis, and evaluation, were performed by 
different technicians 6 years apart. Biobanks consisting of samples 
stored for several years are important data sources in epidemiological 
studies, and for assessing changes in exposure over time. It is therefore 
necessary to continue to evaluate the impact of long-term storage on the 
quality and reliability of biological samples in biobanks. 
4.3. Strengths and limitations 
This study comprises repeated cross-sectional measurements of 
serum concentrations of several PFAAs in adolescents over an extended 
period of 17 years. Compared with similar studies covering more than 
10 years of data, this study was based on a large population that was 
homogenous in terms of geographic area, number of participants per 
sample collection, and age of study participants throughout the study 
period, which is ideal for studying time trends. All samples in the study 
were analyzed between year 2018 and 2020 using the same instruments 
and QC samples. 
One expected limitation was that the recruitment process changed in 
the cohorts after 2009 that might affect the trend results, considering 
previously reported sex-differences in PFAA concentrations (Goralczyk 
et al., 2015; Harada et al., 2005). Additionally, the recruitment through 
schools in 2013 and 2017 might have introduced selection bias, with 
individuals having greater interest in or awareness of chemical exposure 
being more willing to participate. Still, a strength of our study design is 
that the possible sex differences were assessed, and that we did not 
observe any substantial differences in median concentrations or time 
trends when excluding women from the analyses. Concerning external 
validity, both the measured concentrations and trend patterns were very 
similar to findings from other parts of the world. Nevertheless, the 
comparability of the present results to those in other studies might be 
limited to studies of similar age groups in Western countries, because of 
differences in lifestyle factors and the long elimination half-lives of the 
compounds, and to studies of the general population without additional 
exposure to PFAAs from contaminated drinking water. 
5. Conclusions 
We found widespread exposure to PFHxS, PFOS, PFOA, PFNA, and 
PFDA in Swedish adolescents. Compounds that decreased in serum 
concentration over time were PFOS by 12.5% per year, PFOA by 6.5%, 
and PFHxS by 6.0%. PFNA and PFDA displayed an inversed u-shaped 
pattern over time, with a peak in serum concentrations around 2009, 
between 2004 and 2013. The observed patterns over time are consistent 
with the timing of important steps to phase out these compounds by the 
major manufacturers, the US EPA, and the EU. All trends remained after 
excluding women from the sensitivity analyses. Year explained a high 
proportion (R2 = 44–81%) of the variation in concentrations of PFOS, 
PFHxS, and PFOA. Furthermore, concentrations of PFOS, PFHpA, PFOA, 
PFNA, PFDA, and PFUnDA were highly correlated in the same samples 
analyzed before and after storage, confirming that PFAAs remain stable 
in stored serum samples for at least 6 years. Our main findings suggest 
that voluntary and regulatory actions taken to mitigate exposure to 
specific PFAAs in the USA and EU have had an impact on the exposure in 
our study population of adolescents in the general population in 
southern Sweden. 
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